Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

A replay of both events will be available in the Investors section on the Company's website at www.soleno.life.

today announced that it will be presenting data from its DCCR clinical development program for the treatment of Prader-Willi syndrome (PWS) at the 62nd Annual European Society for Paediatric ...

in order to raise awareness of such cases and to enhance our knowledge regarding the diagnosis and prompt treatment of this particular PWS patients. Prader-Willi syndrome (PWS, OMIM176270) is a rare ...

Katie Price stunned fans by sharing a video appearing to pick fun at an overweight man, despite having raged about 'disgusting' trolls who bully her own son Harvey ...

Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't disclose any terms in its SEC filing, but indicated in its filing fee schedule ...

Cystic-fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...

Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.